Daxor Launches 98% Accurate BVA Outpatient Program in Tennessee with 24h Turnaround
Daxor opened a new BVA diagnostic program in Southern Middle Tennessee, leveraging its Tennessee-based ezBVA Lab workflow for 24-hour turnaround and 98% accuracy. The outpatient integration requires zero capital investment and targets high-volume cardiology preventive care, aiming to drive clinical decision speed and reduce healthcare costs.
1. Outpatient Expansion in Tennessee
Daxor has established a new Blood Volume Analysis (BVA) diagnostic program at a leading outpatient cardiology facility in Southern Middle Tennessee, marking its first regional expansion into preventive care settings. This move positions Daxor to capture a larger share of the outpatient cardiology market by offering advanced diagnostic services outside hospital settings.
2. ezBVA Lab Workflow and Accuracy
The program utilizes Daxor’s proprietary Tennessee-based ezBVA Lab workflow, delivering comprehensive blood volume metrics with a 24-hour turnaround and 98% accuracy. Clinicians gain rapid, data-driven insights to manage fluid levels in chronic disease patients, moving beyond estimation to precise measurement.
3. Financial and Clinical Implications
By deploying the program with zero capital expenditure, Daxor removes a key barrier for facility adoption and leverages existing reimbursement codes to drive revenue. The integration is expected to improve patient outcomes, shorten care cycles, and reduce overall healthcare costs through more targeted fluid management.